A clinical trial to Assess theImmunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent Vaccine DTwP-Hib-HepB in Indian infants
Phase 3
Completed
- Registration Number
- CTRI/2011/11/002118
- Lead Sponsor
- ovartis Healthcare Pvt Ltd Vaccines Division
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 175
Inclusion Criteria
Healthy infants without any contradictions to receive investigational vaccine
Exclusion Criteria
1.Parents unwilling or unable to provide written informed consent
2. History of previous immunization with a vaccine containing any of the 5 antigen components of investigational vaccine.
3.Known hypersensitivity or allergic reactions after previous vaccinations
4.Presence of any significant medical condition
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method